Integra LifeSciences (IART) Proxy filing summary

Executive summary

• Annual Meeting scheduled for May 7, 2026, at corporate headquarters in Princeton, NJ.

• Supplement provides updated information regarding board and executive leadership changes.

Voting matters and shareholder proposals

• Ms. Mojdeh Poul, previously listed as a director nominee, will not stand for election due to her departure.

• Proxies instructing votes for Ms. Poul will not be counted for her but will be valid for other matters.

• No new proxy cards will be issued; shareholders may disregard Ms. Poul's name when voting.

Board of directors and corporate governance

• Dr. Stuart M. Essig appointed President and CEO effective May 1, 2026, while continuing as Chairman.

• Board size reduced from eight to seven following Ms. Poul's departure.